CNS Treatment Developer Supernus Pharma (SUPN) Lowers IPO Expectations

Go back to CNS Treatment Developer Supernus Pharma (SUPN) Lowers IPO Expectations
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 46.84 -0.8 (1.68%)
Previous Close $47.64    52 Week High $26.84 
Open $47.11    52 Week Low $9.51 
Day High $47.72    P/E N/A 
Day Low $46.77    EPS $-2.62 
Volume 175,717